Two San Diego startups and Kratos SRE made the Pentagon’s Gauntlet shortlist. The trials begin next week and could lead to sizable prototype orders.

Federal and UK cyber agencies warn that unsupported routers, firewalls and VPNs are being targeted by nation‑state actors. Local IT teams should inventory, patch or replace at‑risk gear.

Halozyme raised 2026 guidance and acquired two hyperconcentration firms, projecting faster royalty growth and several clinic starts that could reshape local drug‑delivery work.

A San Diego‑led team mapped nine CD8 T‑cell states and identified two transcription factors that revive exhausted T cells without erasing immune memory. The finding points to new cell‑therapy strategies.

San Diego biotech Neomorph has dosed the first patient in a Phase 1/2 trial of NEO‑811, a molecular glue for clear‑cell kidney cancer, after landing multibillion‑dollar pharma deals. Early safety and activity readouts will be the near‑term test.

Salk Institute scientists mapped a rapid immune switch in plants that flips on minutes after rewatering; the discovery could guide new drought‑resilient crops.

Illumina has completed its acquisition of SomaLogic, folding the SomaScan proteomics platform and a Boulder lab into its multiomics push.

Veerabhadran Ramanathan was awarded the 2026 Crafoord Prize for his climate change research, highlighting particulate and gas impacts on the atmosphere.

Bora Biologics opened a $30M expansion in Sorrento Valley, adding 2,000L bioreactors and upgraded GMP processing to boost local biologics capacity.

NIH announced it will no longer fund research using fetal tissue from elective abortions, citing alternatives; scientists warn it could slow vital studies on disease and development.

The U.S. and Taiwan struck a $250B trade-and-investment framework that cuts reciprocal tariffs to 15% and ties relief to major Taiwanese investment in U.S. chipmaking. The deal names TSMC as a lead investor and promises new industrial parks and tariff exemptions for certain imports.

The SpaceX Crew-11 mission ended with a splashdown after over five months on the ISS due to a medical issue. The crew underwent postflight reconditioning. They celebrated 25 years of continuous human presence on the ISS.

Illumina unveiled a Billion Cell Atlas mapping how 1 billion single cells respond to gene edits, aiming to train AI and speed drug discovery.